Abera Bioscience AB
556909-0904ActiveDeveloping next-generation nasal vaccines using modular OMV platform technology.
Biotechnology Company / Vaccine Developeraberabio.com
Yleiskatsaus
- Tuntematon
- Työntekijät
- Tuntematon
- Liikevaihto
- 2012
- Perustettu
Avainpäättäjät
Maria Alriksson
CEO
@aberabio.com+46704XXXXXX
Mats Lundgren
CSO
@aberabio.com
Anders Ericsson
Executive Chairman of the Board
@aberabio.com
Joen Luirink
CTO, Co-Founder
@aberabio.com
+3 lisää yhteystietoja Funnelfeedrissä
Kuvaus
Abera Bioscience AB is a Swedish biotechnology company specializing in the development of next-generation vaccines. They utilize a proprietary, modular Outer Membrane Vesicle (OMV) platform technology. This platform allows for rapid design and cost-effective production of vaccines that induce robust...
APTAMEDICA AB